Among other antimetabolite drugs, L-Asparaginase (L-ASNase) is commonly used in clinical practice as a conventional therapy for acute lymphoblastic leukemia (ALL) [6], and, recently, its possible application in non-hematological tumors has been proposed and investigated [7]. This evidence concerns the gene ASPG and acute lymphoblastic leukemia.